Product Information
GNP DICLOFENAC SODIUM 1% GEL is a generic product labeled by AmerisourceBergen, priced at $0.0813 per GM under NDC 46122075252. Its NADAC has been published 160 times since Sep 13, 2023.
FDA first approved this application on Mar 18, 2016.
Strength
10 mg/g
Manufacturer
AmerisourceBergenNDC
46122075252
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
DICLOFENAC SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA208077FDA Approved
3/18/2016
On Market Since
4/1/2023
Pharmacological Classes
Price Statistics
The NADAC for GNP DICLOFENAC SODIUM 1% GEL has been published 160 times since Sep 13, 2023, and over the history we have for it it has declined 12.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0813 per GM |
|---|---|
| All-time high | $0.1029 (Mar 13, 2024) |
| All-time low | $0.0788 (Jul 17, 2024) |
| 52-week high | $0.0953 |
| 52-week low | $0.0813 |
| Median price | $0.0908 |
| Average price | $0.0903 |
| Largest weekly change | +20.8% (Aug 21, 2024) |
| Weeks tracked | 160 |
| Tracking since | Sep 13, 2023 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diclofenac sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP DICLOFENAC SODIUM 1% GEL?
The current National Average Drug Acquisition Cost (NADAC) for GNP DICLOFENAC SODIUM 1% GEL, manufactured by AmerisourceBergen, is $0.0813 per GM (NDC 46122075252), effective Sep 30, 2026.
How has the price of GNP DICLOFENAC SODIUM 1% GEL changed over time?
Over the history we have for it, the NADAC for GNP DICLOFENAC SODIUM 1% GEL has declined 12.2%. It has been tracked across 160 weekly CMS publications since Sep 13, 2023.
What are the highest and lowest recorded NADAC prices for GNP DICLOFENAC SODIUM 1% GEL?
Since Sep 13, 2023, the NADAC for GNP DICLOFENAC SODIUM 1% GEL has ranged from a low of $0.0788 (Jul 17, 2024) to a high of $0.1029 (Mar 13, 2024), with a median of $0.0908 per GM.
Are there cheaper alternatives to GNP DICLOFENAC SODIUM 1% GEL?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DICLOFENAC SODIUM 1% GEL, is $0.0689 per GM — about 15% below GNP DICLOFENAC SODIUM 1% GEL.
Who manufactures GNP DICLOFENAC SODIUM 1% GEL?
GNP DICLOFENAC SODIUM 1% GEL (NDC 46122075252) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.